Antipsychotic amides

7300 FITS SET

The Brownlee SPP RP-Amide phase offers increased retention and selectivity of many polar compounds, includng acids and zwitterions and yields symmetrical peak shapes of bases.

The Brownlee SPP RP-Amide phase offers increased retention and selectivity of many polar compounds, includng acids and zwitterions and yields symmetrical peak shapes of bases.

The Brownlee SPP RP-Amide phase offers increased retention and selectivity of many polar compounds, includng acids and zwitterions and yields symmetrical peak shapes of bases.

The Brownlee SPP RP-Amide phase offers increased retention and selectivity of many polar compounds, includng acids and zwitterions and yields symmetrical peak shapes of bases.

The Brownlee SPP RP-Amide phase offers increased retention and selectivity of many polar compounds, includng acids and zwitterions and yields symmetrical peak shapes of bases.

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).

Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).